Development of Robust Cationic Light-Activated Thermosensitive Liposomes: Choosing the Right Lipids.

Mol Pharm

Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, FI-00790 Helsinki, Finland.

Published: November 2023

Extensive research has been conducted on cationic light-activated thermosensitive liposomes (CLTSLs) as a means for site-specific and controlled drug release; however, less attention has been given to the stability of these nanoparticles. Selecting the appropriate lipids is crucial for the development of a stable and responsive system. In this study, we investigated the impact of various lipids on the physical properties of cationic light-activated liposomes. Incorporating poly(ethylene glycol) PEG molecules resulted in uniform liposomes with low polydispersity index, while the addition of unsaturated lipid (DOTAP) resulted in extremely leaky liposomes, with almost 80% release in just 10 min of incubation at body temperature. Conversely, the inclusion of cholesterol in the formulation increased liposome stability too much and decreased their sensitivity to stimuli-responsive release, with only 14% release after 2 min of light exposure. To achieve stable and functional CLTSL, we substituted an equivalent amount of unsaturated lipid with a saturated lipid (DPTAP), resulting in stable liposomes at body temperature that were highly responsive to light, releasing 90% of their content in 10 s of light exposure. We also conducted two atomistic molecular dynamics simulations using lipid compositions with saturated and unsaturated lipids to investigate the effect of lipid composition on the dynamical properties of the liposomal lipid bilayer. Our findings suggest that the nature of lipids used to prepare liposomes significantly affects their properties, especially when the drug loading needs to be stable but triggered drug release properties are required at the same time. Selecting the appropriate lipids in the right amount is therefore essential for the preparation of liposomes with desirable properties.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630945PMC
http://dx.doi.org/10.1021/acs.molpharmaceut.3c00602DOI Listing

Publication Analysis

Top Keywords

cationic light-activated
12
light-activated thermosensitive
8
liposomes
8
thermosensitive liposomes
8
drug release
8
selecting appropriate
8
appropriate lipids
8
unsaturated lipid
8
release min
8
body temperature
8

Similar Publications

Structural Insights Into the Opening Mechanism of C1C2 Channelrhodopsin.

J Am Chem Soc

December 2024

PSI Center for Life Sciences, Laboratory for Biomolecular Research, Paul Scherrer Institut, Villigen 5232, Switzerland.

Channelrhodopsins, light-gated cation channels, enable precise control of neural cell depolarization or hyperpolarization with light in the field of optogenetics. This study integrates time-resolved serial crystallography and atomistic molecular dynamics (MD) simulations to resolve the structural changes during C1C2 channelrhodopsin activation. Our observations reveal that within the crystal environment, C1C2 predominantly remains in a light-activated state with characteristics of the M intermediate.

View Article and Find Full Text PDF

Upconversion Nanoparticle-Anchored Metal-Organic Framework Nanostructures for Remote-Controlled Cancer Optogenetic Therapy.

J Am Chem Soc

December 2024

School of Chemistry, Chemical Engineering, and Biotechnology, Nanyang Technological University, 21 Nanyang Link, Singapore 637371, Singapore.

Optogenetics, a revolutionary technique utilizing light-sensitive proteins to control cellular functions with high spatiotemporal precision, presents a promising avenue for disease treatment; however, its application in cancer therapy remains constrained by limited research. Herein, we introduce a pioneering strategy for remote-controlled optogenetic cancer therapy, synergistically merging optogenetics with ion therapy, which incorporates ion self-supply, in situ ion channel construction, and near-infrared (NIR) light-activated ion therapy, facilitating remote and noninvasive manipulation of cellular activities in deep tissues and living animals. We report the facile synthesis of water-dispersible upconversion nanoparticle (UCNP)-metal-organic framework (MOF) nanohybrids capable of effectively delivering plasmid DNA to cancer cells, thereby enabling the in situ expression of photoactivatable cation channels.

View Article and Find Full Text PDF

Light-Activated Gene Expression System Using a Caging-Group-Free Photoactivatable Dye.

Angew Chem Int Ed Engl

October 2024

Department of Applied Chemistry, Graduate School of Engineering, Osaka University, 2-1, Yamadaoka, Suita, Osaka, 5650871, Japan.

Optical regulation of transcription using chemical compounds is an effective strategy to manipulate gene expression spatiotemporally. Conventional caging approaches with photoremovable protecting groups may require intense UV-light exposure and release potentially toxic byproducts. To address these problems, here we developed a light-mediated transcriptional regulation system by combining a caging-group-free photoactivatable dye PaX and a multidrug-binding transcriptional regulator QacR.

View Article and Find Full Text PDF
Article Synopsis
  • Ligands like insulin and growth factors activate receptor tyrosine kinases (RTKs) at the cell membrane, which are key for converting external signals into internal responses.
  • * RTKs interact with multiple signaling pathways (e.g., MAP/ERK, PLCγ, PI3K), making it difficult to study their individual effects.
  • * The study employed optogenetics and click chemistry to selectively activate PI3K, revealing that its activation alone can successfully promote the movement of TRPV1 ion channels and insulin receptors to the plasma membrane.
View Article and Find Full Text PDF

Light-Inducible Activation of TrkA for Probing Chronic Pain in Mice.

ACS Chem Biol

July 2024

Department of Chemistry, Stanford University, Stanford, California 94305, United States.

Chronic pain is a prevalent problem that plagues modern society, and better understanding its mechanisms is critical for developing effective therapeutics. Nerve growth factor (NGF) and its primary receptor, Tropomyosin receptor kinase A (TrkA), are known to be potent mediators of chronic pain, but there is a lack of established methods for precisely perturbing the NGF/TrkA signaling pathway in the study of pain and nociception. Optobiological tools that leverage light-induced protein-protein interactions allow for precise spatial and temporal control of receptor signaling.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!